Author Correction: An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients

Sci Rep. 2022 Jun 20;12(1):10389. doi: 10.1038/s41598-022-15107-8.

¹ Department of Nephrology, MIOT International, Chennai, 600089, India.
² Adjunct Faculty, Indian Institute of Technology Madras (IITM), Chennai, Tamil Nadu, 600036, India.
³ Departments of Biochemistry, Molecular Virology and Research, Panimalar Medical College Hospital and Research Institute, Chennai, Tamil Nadu, 600123, India.
⁴ Department of General Medicine, Panimalar Medical College Hospital and Research Institute, Chennai, Tamil Nadu, 600123, India.
⁵ Departments of Pharmacology and Research, Panimalar Medical College Hospital and Research Institute, Chennai, Tamil Nadu, 600123, India.
⁶ Departments of Microbiology and Molecular Virology, Panimalar Medical College Hospital and Research Institute, Chennai, Tamil Nadu, 600123, India.
⁷ Molbio Diagnostics Private Limited, Verna Industrial Estate, Verna, Goa, 403 722, India.
⁸ School of Life Sciences, Manipur University, Imphal, Manipur, 795003, India.
⁹ Department of Engineering Design, IITM, Chennai, Tamil Nadu, 600036, India. rkkumar@iitm.ac.in.

No abstract available

Publication types